Magnesium by diet or skin lotion for people with lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This early study tests whether replacing magnesium—either by diet or a topical (skin) supplement—can improve safety or other health measures in people with lymphoma. It focuses on people who have a slightly low magnesium level and checks blood magnesium repeatedly during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have had lymphoma now or in the past
- Be off strong chemo for at least 2 months (some steady medicines like rituximab maintenance or certain oral cancer drugs may still be allowed)
- Have a recent blood magnesium level between 1.5 and 1.9 mg/dL
- Be able to eat regular meals by mouth, including foods with seeds and nuts (no feeding tube or swallowing problems)
- Be able to come for visits at baseline, 4 weeks, and 8 weeks, and do a 1-day food record for the prior day
- Be willing to get blood drawn for magnesium every 2 weeks at a Mayo Clinic site
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if eating more fruits and vegetables can help reduce persistent fatigue in people with lymphoma. You will receive questionnaires by email to track your fatigue and diet over time.
This trial tests a personalized supportive care program that combines exercise, nutrition, and coaching to help reduce fatigue in people with certain slow-growing lymphomas. It aims to improve energy and quality of life.
This trial tests if adding magnesium supplements to standard first-line treatment (chemotherapy plus immunotherapy) improves outcomes for people with advanced non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It is for patients who have not had prior treatment for metastatic disease.
This study looks at whether magnesium levels in the blood are different in people with lipedema. It aims to see if checking magnesium could be helpful for managing the condition.
This trial tests if magnesium supplements can help reduce nerve damage (peripheral neuropathy) caused by chemotherapy. It also looks at how magnesium affects sleep and quality of life in people with colorectal cancer.
This Phase 2 study tests MLD10 to help people with type 2 diabetes who have low magnesium levels. If you qualify, you may receive the study treatment to see if it improves magnesium-related health in a safe way.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.